← Open Payments lookup

KATHLEEN TATE: Open Payments

NPI 1922614171 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$836 in 27 payments from 13 companies in 2025. Trend: 2023 $166 · 2024 $1,278 · 2025 $836

Food & beverage: $836
CompanyPaymentsAmount
Phathom Pharmaceuticals, Inc.2$144
Janssen Scientific Affairs, LLC1$132
Ardelyx, Inc.3$121
Janssen Biotech, Inc.6$108
Novo Nordisk Inc2$93
ABBVIE INC.3$59
Takeda Pharmaceuticals U.S.A., Inc.2$39
Ferring Pharmaceuticals Inc.2$31
Celltrion USA Inc.2$29
Aimmune Therapeutics, Inc.1$22

Products named: TREMFYA, VOQUEZNA, IBSRELA, Wegovy, ENTYVIO, SKYRIZI, REBYOTA, VEGZELMA.

Industry payments across MS — which companies pay providers there.